Home / Inspections / 1162216

FDA Inspection 1162216 — Fresenius Kabi Austria GMBH

Fresenius Kabi Austria GMBH — FEI 3003708554

The FDA completed an inspection of Fresenius Kabi Austria GMBH on January 30, 2020 in Graz. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 30, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Graz (Austria)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1251340 (VAI Thu Mar 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1207391 (VAI Thu Oct 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1094504 (VAI Thu Feb 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1005862 (VAI Fri Mar 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 969912 (NAI Fri Apr 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources